Browsing by Subject "ENDPRODUCTS"

Sort by: Order: Results:

Now showing items 1-2 of 2
  • Januszewski, Andrzej S.; Chen, David; Scott, Russell S.; O'Connell, Rachel L.; Aryal, Nanda R.; Sullivan, David R.; Watts, Gerald F.; Taskinen, Marja-Riitta; Barter, Philip J.; Best, James D.; Simes, R. John; Keech, Anthony C.; Jenkins, Alicia J. (2021)
    People with diabetes are at risk of chronic complications and novel biomarkers, such as Advanced glycation end-products (AGEs) may help stratify this risk. We assessed whether plasma low-molecular weight AGEs, also known as LMW-fluorophores (LMW-F), are associated with risk factors, predict complications, and are altered by fenofibrate in adults with type 2 diabetes. Plasma LMW-F were quantified at baseline, after six weeks fenofibrate, and one year post-randomisation to fenofibrate or placebo. LMW-F associations with existing and new composite vascular complications were determined, and effects of fenofibrate assessed. LMW-F correlated positively with age, glycated haemoglobin (HbA1c), pulse pressure, kidney dysfunction and inflammation; and negatively with urate, body mass index, oxidative stress and leptin, albeit weakly (r = 0.04-0.16, all p < 0.01). Independent determinants of LMW-F included smoking, diastolic blood pressure, prior cardiovascular disease or microvascular complications, Caucasian ethnicity, kidney function, HbA1c and diabetes duration (all p
  • Iwamoto, Hiroshi; Gao, Jing; Pulkkinen, Ville; Toljamo, Tuula; Nieminen, Pentti; Mazur, Witold (2014)